Technology
M&A Advisory
M&A Advisory
Lazard
Full Credential Description
Ziopharm Oncology. United States. Announced Date 20/01/2012. Closed Date 25/01/2012. Deal value: $50m. Common stock. Industry: Ziopharm Oncology is a biotechnology company focused on developing cancer therapies.